Subscribe To

Price Alert Latest News Economic Calendar News

LIVN / LivaNova's Neuromodulation Products Could Imply Significant Undervaluation

LivaNova provides high-tech medical devices for the benefit of healthcare professionals, patients, and healthcare systems around the world. Considering the geographic diversification of the business model, LivaNova's revenue model appears to be more solid than that of competitors that operate only in one market. Read More

Demo Live Account See Partner Details

Content Topics

Livanova

Neuromodulation

Products

Could

Imply

Significant

Livanova s

Undervaluation

Stock

LIVN

Posted: Feb 14 2023, 22:54

Author Name: Seeking Alpha

LIVN News

By Seeking Alpha
November 1, 2023

LivaNova PLC (LIVN) Q3 2023 Earnings Call Transcript

LivaNova PLC (NASDAQ:LIVN ) Q3 2023 Earnings Conference Call November 1, 2023 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President, C

By Zacks Investment Research
July 26, 2023

LivaNova (LIVN) Q2 Earnings and Revenues Beat Estimates

LivaNova (LIVN) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earning

By Seeking Alpha
May 7, 2023

LivaNova PLC (LIVN) Q1 2023 Earnings Call Transcript

LivaNova PLC (NASDAQ:LIVN ) Q1 2023 Earnings Conference Call May 3, 2023 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President of Corp

By Zacks Investment Research
May 3, 2023

LivaNova (LIVN) Beats Q1 Earnings and Revenue Estimates

LivaNova (LIVN) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earning

By Zacks Investment Research
April 18, 2023

Strength Seen in LivaNova (LIVN): Can Its 12.7% Jump Turn into More Strength?

LivaNova (LIVN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revision

By Zacks Investment Research
March 15, 2023

LivaNova (LIVN) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

After losing some value lately, a hammer chart pattern has been formed for LivaNova (LIVN), indicating that the stock has found support. This, combine

By Zacks Investment Research
February 28, 2023

Down -12.75% in 4 Weeks, Here's Why You Should You Buy the Dip in LivaNova (LIVN)

LivaNova (LIVN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among W

By Zacks Investment Research
February 22, 2023

LivaNova (LIVN) Q4 Earnings and Revenues Beat Estimates

LivaNova (LIVN) delivered earnings and revenue surprises of 12.50% and 4.12%, respectively, for the quarter ended December 2022. Do the numbers hold c

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.